PR Newswire
04 Oct 2022, 17 GMT+10
EAST RUTHERFORD, NJ, Oct. 4, 2022 /PRNewswire/ -- Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will open a new 20,000-square-foot cGMP facility in Belgium and add an additional 10,000 square feet at their existing facility in Waterford, Ireland. The expansions will be completed in the first half of 2023.
Q1 Scientific's new state-of-the-art temperature-controlled and monitored storage facility in Belgium will be located in the easily accessible Liege region, approximately 50 miles from Brussels. The facility will provide 35,000 temperature-controlled storage spaces for all key ICH climatic zones, supporting long-term, intermediate and accelerated stability trials, including 2 - 8C and 25C / 60%RH and 40C / 75%RH.
Tom Loewald, CEO at Cambrex says, "We are delighted to expand the Q1 Scientific business into Belgium, where we will be able to serve pharmaceutical companies across Germany, France, and the Netherlands. Simultaneously, we will continue to expand our Waterford facility to meet the demand within the Irish market."
Q1 Scientific's Waterford-based facility has doubled in size over the past two years and continues to grow with this new 10,000-square-foot expansion.
"With Cambrex's scientific expertise and scale, we are able to accelerate our growth plans and launch a second site in 2023," added Stephen Delaney, Managing Director of Q1 Scientific. "Operating two sites will be a great benefit to our European customers, who can now expect even faster turnaround times for the return of samples. Meanwhile, we will also be able to provide greater temperature-controlled transport options in mainland Europe."
Cambrex continues to expand its capabilities and capacity across its North American and European network to meet the growing demand for outsourced drug development and manufacturing services.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,300 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments
About Q1 Scientific, a Cambrex company
Q1 Scientific, a Cambrex company, was founded in Waterford, Ireland in 2013 by Louise Grubb, and offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries at their 20,000 sq ft. cGMP facility. As the first company in the sector to establish in Ireland, Q1 Scientific is revolutionising the way pharmaceutical companies store their products, helping to improve the speed it takes for new drugs to reach the marketplace along with saving companies the expense of building and monitoring their own storage chambers. In June 2022, Q1 Scientific was acquired by US company Cambrex.
SOURCE Cambrex
Get a daily dose of Malaysia Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.
More InformationDHAKA, Bangladesh - Human Rights Watch has sharply criticized a plan to repatriate Rohingya refugees from Bangladesh to Myanmar, claiming ...
Diamir, Pakistan - According to the country's disaster management agency, at least 11 people were killed when an avalanche hit ...
KATHMANDU, Nepal - According to sources, Luis Stitzinger, the expedition leader of the German operator Amical Alpin, has remained out ...
KARACHI, Pakistan - Dr. Seemin Jamali, former executive director of the Jinnah Postgraduate Medical Centre (JPMC), died on Saturday night ...
RAKHINE STATE, Myanmar - According to Myanmar's ruling military, Cyclone Mocha killed at least 145 people this week.The impoverished western ...
KATHMANDU, Nepal - Nepal Airlines, the country's state-owned carrier, is one step closer to starting flights to Australia. Nepal Airlines' ...
FRANKFURT, Germany - With U.S. and UK. markets closed for public holidays, it was left to European and broader global ...
NEW YORK CITY, New York: The Verge has reported that Verizon Communications met with more than 6,000 customer service employees ...
WASHINGTON D.C.: In response to a safety warning issued by the US National Highway Traffic Safety Administration, Vietnamese electric vehicle ...
NEW YORK CITY, New York: Electric truck manufacturer Nikola Corp said that Nasdaq has delivered a delisting notice for not ...
MINNEAPOLIS, Minnesota: Reuters reported that after facing a backlash from customers, Target is pulling some products from its Pride Collection ...
LONDON, England: The BBC has reported that Jaguar Land Rover owner Tata Motors is planning to build a multi-billion pound ...